ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Epidemiologic methods"

  • Abstract Number: 243 • 2013 ACR/ARHP Annual Meeting

    The Association Between Metabolic Syndrome and Hand Osteoarthritis – Data From The Framingham Study

    Ida K. Haugen1, Vasan Ramachandran2,3, Devyani Misra4, Tuhina Neogi4, Jingbo Niu4, Yuqing Zhang5 and David T. Felson5, 1Rheumatology, Diakonhjemmet Hospital, Oslo, Norway, 2Section of Preventive Medicine and Epidemiology, Boston University School of Medicine, Boston, MA, 3Cardiology, Boston University School of Medicine, Boston, MA, 4Clinical Epidemiology Research and Training Unit, Boston University School of Medicine, Boston, MA, 5Clinical Epidemiology Unit, Boston University School of Medicine, Boston, MA

    Background/Purpose: Metabolic factors may have a negative effect on cartilage, and may be especially relevant in the pathogenesis of hand OA. Our aim was to…
  • Abstract Number: 2829 • 2013 ACR/ARHP Annual Meeting

    Statin Adherence and Risk Of Mortality In Patients With Rheumatoid Arthritis: A Population-Based Study

    Mary De Vera1,2, Michal Abrahamowicz3 and Diane Lacaille4, 1Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, BC, Canada, 2Arthritis Research Centre of Canada, Richmond, BC, Canada, 3Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, 4Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada

    Background/Purpose: Poor adherence with statin therapy is associated with increased mortality in the general population, but no corresponding data are available among patients with rheumatoid…
  • Abstract Number: 1209 • 2013 ACR/ARHP Annual Meeting

    Starting Time Of Inflammatory Attacks In Patients With Familial Mediterranean Fever

    Feyza Berktas1, Nilufer Alpay Kanitez1, Bahtiyar Toz1, Oguz Kaan Bakkaloglu1, Burak Erer2 and Ahmet Gul1, 1Department of Internal Medicine, Rheumatology Division, Istanbul University, Istanbul Faculty of Medicine, Istanbul, Turkey, 2Department of Internal Medicine, Rheumatology Division, Istanbul Faculty of Medicine, Istanbul University, Istanbul, Turkey

    Background/Purpose: Familial Mediterranean fever (FMF), the most common form of the hereditary autoinflammatory diseases, is characterized by recurrent self-limiting attacks of fever and/or serositis accompanied…
  • Abstract Number: 96 • 2013 ACR/ARHP Annual Meeting

    Epidemiology and Health Services Use For Osteoarthritis By First Nations People In Alberta, Canada

    Cheryl Barnabe1, Allyson Jones2, Ed Enns3, Don Voaklander4, Christine Peschken5, Joanne Homik4, John Esdaile6, Sasha Bernatsky7, Brenda Hemmelgarn8 and Deborah Marshall9, 1Medicine, Community Health Sciences, University of Calgary, Calgary, AB, Canada, 2Department of Physical Therapy, University of Alberta, Edmonton, AB, Canada, 3Alberta Bone and Joint Health Institute, Calgary, AB, Canada, 4University of Alberta, Edmonton, AB, Canada, 5Medicine & Community Health Sciences, University of Manitoba, Winnipeg, MB, Canada, 6Medicine, University of British Columbia, Vancouver, BC, Canada, 7Clinical Epidemiology, Research Institute of the McGill University Health Ctre, Montreal, QC, Canada, 8Division of Nephrology, University of Calgary, Calgary, AB, Canada, 9University of Calgary, Calgary, AB, Canada

    Background/Purpose: Self-reported survey data and a single provincial administrative data source have previously indicated that the First Nations (FN) population in Canada has a 1.5…
  • Abstract Number: 2759 • 2013 ACR/ARHP Annual Meeting

    Can RA Registries Provide Contextual Safety Data For Modern RCTs?

    Kaleb Michaud1, Johan Askling2, Hisashi Yamanaka3, Deborah Symmons4, Marie Holmqvist2, Thomas Frisell5, George Reed6, Dimitrios A. Pappas7, Eiichi Tanaka8, Eisuke Inoue9, Suzanne M.M. Verstappen4, Christopher Garwood4, Laura Horne10, Kathy Lampl11, Niklas Berglind12, Stefan Franzen12, Fredrik Nyberg13, Trung Tran14, Meilien Ho15 and Jeffrey D. Greenberg16, 1Rheumatology, National Data Bank for Rheumatic Diseases & University of Nebraska Medical Center, Omaha, NE, 2Karolinska Institutet, Stockholm, Sweden, 3Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan, 4Arthritis Research UK Epidemiology Unit, The University of Manchester, Manchester, United Kingdom, 5Clinical Epidemiology Unit, Dept of Medicine, Karolinska Institutet, Stockholm, Sweden, 6Orthopedics, University of Massachusetts Medical School, Worcester, MA, 7Columbia University, New York, NY, 8Tokyo Women's Medical University, Tokyo, Japan, 9Institute of Rheumatology, Tokyo Women’s Medical University, Tokyo, Japan, 10AstraZeneca, Wilmington, DE, 11AstraZeneca R&D Wilmington, Wilmington, DE, 12AstraZeneca R&D Mölndal, Mölndal, Sweden, 13AstraZeneca R&D, Mölndal, Sweden, 14MedImmune LLC, Gaithersburg, MD, 15AstraZeneca R&D Alderley Park, Macclesfield, United Kingdom, 16New York University School of Medicine, New York, NY

    Background/Purpose: For ethical reasons, modern phase-III RCTs in rheumatoid arthritis (RA) have limited placebo exposure time, resulting in uncertainties when interpreting low frequency adverse events…
  • Abstract Number: 1052 • 2013 ACR/ARHP Annual Meeting

    Glucocorticosteroids and Mortality Risk In Rheumatoid Arthritis – Results Of a Population Based Study

    Diane Lacaille1, J. Antonio Avina-Zubieta2,3, Eric C. Sayre2, Michal Abrahamowicz4 and John Esdaile1,5, 1Rheumatology, Arthritis Research Centre of Canada, University of British Columbia, Richmond, BC, Canada, 2Arthritis Research Centre of Canada, Richmond, BC, Canada, 3Rheumatology, Arthritis Research Centre of Canada, Richmond, BC, Canada, 4Division of Clinical Epidemiology, McGill University, Montreal, QC, Canada, 5Medicine, University of British Columbia, Vancouver, BC, Canada

    Background/Purpose: Glucocorticosteroids (GC) are frequently used in the management of rheumatoid arthritis (RA). Due to their metabolic and immunosuppressive effects, they could increase the risk…
  • Abstract Number: 1088 • 2012 ACR/ARHP Annual Meeting

    Factors Influencing Long-Term Recovery of Total Knee Arthroplasty

    C. Allyson Jones1, Gian S. Jhangri2 and Maria E. Suarez-Almazor3, 1Departments of Physical Therapy and School of Public Health, University of Alberta, Edmonton, AB, Canada, 2School of Public Health, University of Alberta, Edmonton, AB, Canada, 3The Department of General Internal Medicine, The University of Texas, MD Anderson Cancer Center, Houston, TX

    Background/Purpose: Although a number of studies have examined short term outcomes after total knee arthroplasty (TKA), few have prospectively examined the long term trajectory of…
  • Abstract Number: 1016 • 2012 ACR/ARHP Annual Meeting

    The Effect of Evaluation Variability At the Unit of Measurement On the Reliability of Omeract Ramris and Van Der Heijde-Modified Sharp Score

    Ruben Tavares1, Naveen Parasu2, Karen Finlay3, Erik Jurriaans3, Hao Wu1, Karen A. Beattie4, Maggie Larche5, Lawrence E. Hart6, William G. Bensen7, Raja S. Bobba5, Alfred A. Cividino4, Colin E. Webber8, Jean-Eric Tarride9 and Jonathan D. Adachi10, 1McMaster University, Hamilton, ON, Canada, 2Radiology, Hamilton Health Sciences, Hamilton, ON, 3Radiology, Hamilton Health Sciences, Hamilton, ON, Canada, 4Medicine, McMaster University, Hamilton, ON, Canada, 5Rheumatology, McMaster University, Hamilton, ON, Canada, 6Medicine (Rheumatology), St. Joseph's Health Care, Hamilton, ON, Canada, 7Department of Medicine, Division of Rheumatology, St. Joseph's Hospital and McMaster University, Hamilton, ON, Canada, 8Department of Nuclear Medicine, Hamilton Health Sciences, Hamilton, ON, Canada, 9Clinical Epidemiology and Biostatistics (CE&B) and Economics, Programs for Assessment of Technology in Health (PATH) Research Institute, Hamilton, ON, Canada, 10St Joseph's Healthcare Hamilton, Hamilton, ON, Canada

    Background/Purpose: The Outcome Measures in Rheumatology (OMERACT) Rheumatoid Arthritis Magnetic Resonance Imaging Score (RAMRIS) and van der Heijde-modified Sharp score (vdHSS) are recognized semi-quantitative measures…
  • Abstract Number: 1001 • 2012 ACR/ARHP Annual Meeting

    CNstream2: Improved SNP and CNV Genotyping Reveals New Loci Associated with Rheumatic Diseases

    Arnald Alonso, Antonio Julià, Raül Tortosa and Sara Marsal, Rheumatology Research Group, Vall d'Hebron Hospital Research Institute, Barcelona, Spain

    Background/Purpose: In Genome-Wide Association Studies (GWAS), the performance of the genotyping algorithm is crucial to identify new SNPs associated to disease risk. Recently, new methods…
  • Abstract Number: 951 • 2012 ACR/ARHP Annual Meeting

    A Systematic Review of Quality of Prognosis Studies in Systemic Lupus Erythematosus

    Lily Siok Hoon Lim1, Senq-J Lee2, Brian M. Feldman3, D. D. Gladman4, Eleanor Pullenayegum5 and Earl D. Silverman6, 1Pediatric Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, 2Division of Rheumatology, Hospital for Sick Children, Toronto, ON, Canada, 3Division of Rheumatology, The Hospital for Sick Children, Toronto, ON, Canada, 4Division of Rheumatology, Toronto Western Hospital and University of Toronto, Toronto, ON, Canada, 5Clinical Epidemiology & Biostatistics, McMaster University, Hamilton, ON, Canada, 6Rheumatology, Pediatric Rheumatology Collaborative Study Group (PRSCG), Toronto, ON, Canada

    Background/Purpose: Prognosis studies study future outcomes and/or seek to identify predictive or associative factors associated with outcomes. Strong and consistent prognostic factors can be used…
  • Abstract Number: 915 • 2012 ACR/ARHP Annual Meeting

    Incidence of Knee, Hip, and Hand Clinical Osteoarthritis: A Population-Based Cohort Study

    Daniel Prieto-Alhambra1, Aina Pagès-Castellà2, M. Kassim Javaid3, Andrew Judge4, Cyrus Cooper5, Nigel K. Arden6 and Adolfo Díez-Pérez7, 1Internal Medicine; Primary Care; NDORMS Dept; MRC Lifecourse Epidemiology Unit, URFOA-IMIM, Parc de Salut Mar; Idiap Jordi Gol; University of Oxford; University of Southampton, Barcelona, Spain, 2Primary Care, IDIAP Jordi Gol; Institut Català de la Salut, Barcelona, Spain, 3Rheumatology, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, UK, Oxford, United Kingdom, 4Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, 5NDORMS; MRC Lifecourse Epidemiology Unit, University of Oxford; Southampton General Hospital, Southampton, United Kingdom, 6NDORMS; MRC Lifecourse Epidemiology Unit, Oxford NIHR Musculoskeletal Biomedical Research Unit, University of Oxford, Oxford, United Kingdom, 7Internal Medicine, Hospital del Mar-IMIM, Universitat Autònoma de Barcelona, Barcelona; and RETICEF, ISCIII Madrid; Spain, Barcelona, Spain

    TITLE: "Incidence of knee, hip, and hand clinical osteoarthritis: a population-based cohort study."AUTHORS: Daniel Prieto-Alhambra*, Aina Pag�s-Castellˆ, M Kassim Javaid, Andrew Judge, Cyrus Cooper, Nigel…
  • Abstract Number: 911 • 2012 ACR/ARHP Annual Meeting

    Race- and Sex-Specific Estimates of 10-, 20-, 30-Year, and Lifetime Risk of Diagnosed Symptomatic Knee Osteoarthritis and the Need for TKR in the US

    Elena Losina1, Meghan E. Daigle1, Sara A. Burbine1 and Jeffrey N. Katz2, 1Orthopaedic and Arthritis Center for Outcomes Research, Brigham and Women's Hospital, Boston, MA, 2Rheumatology and Orthopedics, Brigham and Women's Hospital, Boston, MA

    Background/Purpose: A growing body of evidence suggests that females are more likely to be diagnosed with knee osteoarthritis (OA) and that obesity increases the risk…
  • Abstract Number: 728 • 2012 ACR/ARHP Annual Meeting

    Does the Use of Angiotensin Converting Enzyme Inhibitors Prior to Scleroderma Renal Crisis Affect Prognosis ? – Results of the International Scleroderma Renal Crisis Survey

    Marie Hudson1, Murray Baron2, Solene Tatibouet1, Daniel Furst3, Dinesh Khanna4 and International Scleroderma Renal Crisis Study Investigaots5, 1Jewish General Hospital, McGill University, Montreal, QC, Canada, 2Pavillion A, Rm 216, Lady David Institute for Medical Research and Jewish General Hospital, Montreal, QC, Canada, 3David Geffen School of Medicine, Div of Rheumatology, University of California at Los Angeles, Los Angeles, CA, 4Division of Rheumatology, University of Michigan Medical Center, Ann Arbor, MI, 5Montreal

    Background/Purpose: Scleroderma renal crisis (SRC) is an infrequent but life-threatening complication of systemic sclerosis (SSc). The outcome of SRC has improved considerably since the advent…
  • Abstract Number: 303 • 2012 ACR/ARHP Annual Meeting

    Ancestral Group Differences in Pediatric SLE Early Disease Severity: An Analysis of the Carranet Registry

    Jennifer M.P. Woo1, Alice DC Hoftman1, Emily von Scheven2, Deborah K. McCurdy3, Ornella J. Rullo1 and CARRA Registry Investigators4, 1Pediatric Rheumatology, Mattel Children's Hospital, University of California, Los Angeles, Los Angeles, CA, 2Pediatric Rheumatology, University of California, San Francisco, San Francisco, CA, 3Pediatric Rheumatology, UCLA Division of Pediatric Rheumatology, Los Angeles, CA, 4Durham, NC

    Background/Purpose: Ancestral background may contribute to increased disease morbidity in patients with pediatric lupus systemic erythematosus (pSLE) of non-European descent; however, there exists a paucity…
  • Abstract Number: 174 • 2012 ACR/ARHP Annual Meeting

    Prevalence, Risk Factors, and Functional Impact of Arthralgias Among Patients with Chronic Hepatitis C Virus Infection

    Samir Bhangle1, Vincent Lo Re2, W. Gina Pang1, Kyong-Mi Chang3, Valerianna Amorosa4, Jay Kostman5, H. Ralph Schumacher6 and Alexis Ogdie7, 1Rheumatology, University of Pennsylvania, Philadelphia, PA, 2Dept of Medicine/Infection Diseases, Dept of Biostatistics and Epidemiology, University of Pennsylvania, Philadelphia, PA, 3Division of Gastroenterology, Philadelphia VA Medical Center, Philadelphia, PA, 4Division of Infectious Diseases, Philadelphia VA Medical Center, Philadelphia, PA, 5Division of Infectious Diseases, University of Pennsylvania, Philadelphia, PA, 6Department of Medicine, University of Pennsylvania and VA Medical Center, Philadelphia, PA, 7Rheumatology and Epidemiology, University of Pennsylvania, Philadelphia, PA

    Background/Purpose: The prevalence, risk factors and functional impact of joint pain are not well described in chronic hepatitis C virus (HCV)-infected patients, particularly in the…
  • « Previous Page
  • 1
  • …
  • 14
  • 15
  • 16
  • 17
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

ACR Abstract Embargo Policy

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. Academic institutions, private organizations and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part a scientific presentation or presentation of additional new information that will be available at the time of the meeting) is under embargo until Saturday, November 11, 2023.

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying financial and other sponsors about this policy. If you have questions about the abstract embargo policy, please contact the public relations department at [email protected].

Copyright Policy

View ACR Policies.

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology